BOLD
Boundless Bio, Inc. Common Stock
NASDAQ: BOLD · HEALTHCARE · BIOTECHNOLOGY
$1.46
+0.69% today
Updated 2026-04-30
Market cap
$33.61M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.60
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Boundless Bio, Inc. Common Stock (BOLD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-46.70%
ROA
-21.90%
Debt/equity
0.50x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | — | $-59.67M | — | — | — |
| 2017 | — | $-90.24M | — | — | — |
| 2018 | — | $-128.82M | — | — | — |
| 2021 | $0.00 | $-25.21M | — | — | — |
| 2022 | $0.00 | $-45.90M | — | — | — |
| 2023 | $0.00 | $-49.43M | — | — | — |
| 2024 | $0.00 | $-65.36M | — | — | — |
| 2025 | $0.00 | $-58.20M | — | — | — |